These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 39056442)

  • 1. Tumor Microenvironment Responsive RNA Drug Delivery Systems: Intelligent Platforms for Sophisticated Release.
    Wang G; Zhang M; Lai W; Gao Y; Liao S; Ning Q; Tang S
    Mol Pharm; 2024 Sep; 21(9):4217-4237. PubMed ID: 39056442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smart Nanoplatforms Responding to the Tumor Microenvironment for Precise Drug Delivery in Cancer Therapy.
    Wang Y; Deng T; Liu X; Fang X; Mo Y; Xie N; Nie G; Zhang B; Fan X
    Int J Nanomedicine; 2024; 19():6253-6277. PubMed ID: 38911497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
    Muntimadugu E; Kommineni N; Khan W
    Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox-manipulating nanocarriers for anticancer drug delivery: a systematic review.
    Meng X; Shen Y; Zhao H; Lu X; Wang Z; Zhao Y
    J Nanobiotechnology; 2024 Sep; 22(1):587. PubMed ID: 39342211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer Therapy.
    Lee S; Lee SA; Shinn J; Lee Y
    Int J Nanomedicine; 2024; 19():4893-4906. PubMed ID: 38828202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research Progress of Disulfide Bond Based Tumor Microenvironment Targeted Drug Delivery System.
    Ma W; Wang X; Zhang D; Mu X
    Int J Nanomedicine; 2024; 19():7547-7566. PubMed ID: 39071505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Microenvironment-Based Stimuli-Responsive Nanoparticles for Controlled Release of Drugs in Cancer Therapy.
    Zhou W; Jia Y; Liu Y; Chen Y; Zhao P
    Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimuli-responsive drug delivery systems for head and neck cancer therapy.
    Liang J; Yang B; Zhou X; Han Q; Zou J; Cheng L
    Drug Deliv; 2021 Dec; 28(1):272-284. PubMed ID: 33501883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Microenvironment Sensitive Nanocarriers for Bioimaging and Therapeutics.
    Park H; Saravanakumar G; Kim J; Lim J; Kim WJ
    Adv Healthc Mater; 2021 Mar; 10(5):e2000834. PubMed ID: 33073497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
    Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
    Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
    [No Abstract]   [Full Text] [Related]  

  • 11. Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers.
    Alshememry AK; El-Tokhy SS; Unsworth LD
    Curr Pharm Des; 2017; 23(35):5358-5391. PubMed ID: 28530543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment-responsive dynamic inorganic nanoassemblies for cancer imaging and treatment.
    Yang Y; Wu H; Liu B; Liu Z
    Adv Drug Deliv Rev; 2021 Dec; 179():114004. PubMed ID: 34662672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotherapy Targeting the Tumor Microenvironment.
    Gong BS; Wang R; Xu HX; Miao MY; Yao ZZ
    Curr Cancer Drug Targets; 2019; 19(7):525-533. PubMed ID: 30569855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facile Synthesis of Fe
    Qi C; Wang W; Wang P; Cheng H; Wang X; Gong B; Xie A; Shen Y
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microenvironment responsive metal nanoparticles in cancer immunotherapy.
    Yang R; Chen L; Wang Y; Zhang L; Zheng X; Yang Y; Zhu Y
    Front Immunol; 2023; 14():1237361. PubMed ID: 37575228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple-negative breast cancer.
    Cao Y; Meng F; Cai T; Gao L; Lee J; Solomevich SO; Aharodnikau UE; Guo T; Lan M; Liu F; Li Q; Viktor T; Li D; Cai Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1950. PubMed ID: 38528388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.
    Sa P; Sahoo SK; Dilnawaz F
    Curr Med Chem; 2023; 30(29):3335-3355. PubMed ID: 36154585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in redox-responsive drug delivery systems of tumor microenvironment.
    Guo X; Cheng Y; Zhao X; Luo Y; Chen J; Yuan WE
    J Nanobiotechnology; 2018 Sep; 16(1):74. PubMed ID: 30243297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-targeted delivery of temozolomide by multi-responsive nanoplatform via tumor microenvironment modulation for overcoming drug resistance to treat glioblastoma.
    Chen X; Zheng Y; Zhang Q; Chen Q; Chen Z; Wu D
    J Nanobiotechnology; 2024 May; 22(1):264. PubMed ID: 38760771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy.
    Yang S; Gao H
    Pharmacol Res; 2017 Dec; 126():97-108. PubMed ID: 28501517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.